Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Bioinorg Chem Appl ; 2013: 637617, 2013.
Article in English | MEDLINE | ID: mdl-24363634

ABSTRACT

The changes in urinary crystal properties in patients with calcium oxalate (CaOx) calculi after oral administration of potassium citrate (K3cit) were investigated via atomic force microscopy (AFM), scanning electron microscopy (SEM), X-ray powder diffractometry (XRD), and zeta potential analyzer. The AFM and SEM results showed that the surface of urinary crystals became concave, the edges and corners of crystals became blunt, the average size of urinary crystallines decreased significantly, and aggregation of urinary crystals was reduced. These changes were attributed to the significant increase in concentration of excreted citrate to 492 ± 118 mg/L after K3cit intake from 289 ± 83 mg/L before K3cit intake. After the amount of urinary citrate was increased, it complexed with Ca(2+) ions on urinary crystals, which dissolved these crystals. Thus, the appearance of concave urinary crystals was a direct evidence of CaOx dissolution by citrate in vivo. The XRD results showed that the quantities and species of urinary crystals decreased after K3cit intake. The mechanism of inhibition of formation of CaOx stones by K3cit was possibly due to the complexation of Ca(2+) with citrate, increase in urine pH, concentration of urinary inhibitor glycosaminoglycans (GAGs), and the absolute value of zeta potential after K3cit intake.

2.
Mater Sci Eng C Mater Biol Appl ; 33(7): 4039-45, 2013 Oct.
Article in English | MEDLINE | ID: mdl-23910312

ABSTRACT

The property changes of urinary nanocrystallites in 20 cases of uric acid (UA) stone formers after 1 week of potassium citrate (K3cit) intake were comparatively studied by X-ray diffraction analysis, Fourier transform infrared spectroscopy, nanoparticle size analysis, and transmission electron microscopy. Before K3cit intake, the urinary crystallites mainly contained UA and calcium oxalate. After K3cit intake, the components changed to urate and UA; the qualities, species, and amounts of aggregated crystallites decreased; urine pH, citrate, and glycosaminoglycan excretions increased; and UA excretion, Zeta potential, and crystallite size decreased. The stability of crystallites followed the order: controls>patients after taking K3cit>patients before taking K3cit. Therefore, the components of urinary stones were closely related to the components of urinary crystallites.


Subject(s)
Nanoparticles/chemistry , Potassium Citrate/administration & dosage , Potassium Citrate/therapeutic use , Uric Acid/urine , Urinary Calculi/drug therapy , Urinary Calculi/urine , Adult , Aged , Case-Control Studies , Citric Acid/urine , Female , Glycosaminoglycans/urine , Humans , Hydrogen-Ion Concentration , Male , Middle Aged , Nanoparticles/ultrastructure , Particle Size , Spectroscopy, Fourier Transform Infrared , Static Electricity , Time Factors , X-Ray Diffraction , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...